1715 38TH ST, BOULDER, CO
Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs
Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Financial Results, Press Release
News
Reports First Quarter 2025 Financial Results and Recent Business Highlights
Investor Presentation
FY 2024
Q3
Q2
Q1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Registration Statement for Additional Securities
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report